CLRB Q1 2026 Earnings EPS Surprise Signals Progress Despite PreRevenue Status American Assets Trust AAT Q1 2026 Earnings EPS Miss of 28 but Shares Edge Higher CNTA Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline UMBFO Q1 2026 Earnings Preferred Stock Performance Strong as EPS Surpasses Estimates by 1728 CCCC Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction NeuroOne Medical Technologies NMTC Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues to Invest in Development Seaport Entertainment Group SEG Q1 2026 Earnings EPS Misses Estimates Amid Operational Transition NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Operational Discipline LNKB Q4 2025 Earnings EPS Falls 57 Short of Estimates Shares Flat DFDV Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Weak Performance LSTA Q3 2025 Earnings Narrowerthanexpected Loss Highlights Operational Progress DSGN Q1 2026 Earnings Narrowerthanexpected loss drives positive sentiment